May
Drug Discovery Biology & Bioinformatics Strategy Dinner
Season 52, 3535 US-1 Suite 100B Princeton, NJ 08540Our Agenda
Why you should attend
At Curia the journey to medical breakthrough may be linear, but it’s never simple. From discovery through manufacturing, launch through commercialization, we leverage deep scientific expertise and state-of-the-art technology to ensure every stage of this intricate process advances as quickly and accurately as possible.
Meet Our Facilitator
Christopher Conway
President, Research and Development Curia
Dr. Grant Carr
Vice President, Head of Global R&D Drug Discovery Curia
Douglas Kitchen
Research Fellow, Medicinal Chemistry Curia
Jim LaRocque
Senior Research Scientist III, Assay Development & Screening Curia
Matthew Surman
Associate Director, Medicinal Chemistry Curia
More about Curia
Curia is a Contract Research, Development and Manufacturing Organization with over 30 years of experience, an integrated network of 27 global sites and over 3,500 employees partnering with customers to make treatments broadly accessible to patients. Our biologics and small molecules offering spans discovery through commercialization, with integrated regulatory and analytical capabilities. Our scientific and process experts and state of the art facilities deliver best-in-class experience across drug substance and drug product manufacturing. From curiosity to cure, we deliver every step to accelerate and sustain life-changing therapeutics. To learn more visit us at curiaglobal.com
Further Information
Interested in attending this virtual roundtable or running your own? Drop us a message today and we will get in touch
Here To Help
Need help registering your team? Just get in touch and a member of the team will be happy to help.
Payment Securely powered by stripe
